期刊
PHARMACEUTICAL RESEARCH
卷 17, 期 5, 页码 497-504出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1023/A:1007502828372
关键词
tissue engineering; growth factors; controlled release; bone; nerve; liver
资金
- NHLBI NIH HHS [R37-HL18672] Funding Source: Medline
- NIAMS NIH HHS [R29-AR42539] Funding Source: Medline
- NINDS NIH HHS [P01-NS23326] Funding Source: Medline
A tissue-engineered implant is a biologic-biomaterial combination in which some component of tissue has been combined with a biomaterial to create a device for the restoration or modification of tissue or organ function. Specific growth factors, released from a delivery device or from co-transplanted cells. would aid in the induction of host paraenchymal cell infiltration and improve engraftment of co-delivered cells for more efficient tissue regeneration or ameliorate disease states. The characteristic properties of growth factors are described to provide a biological basis for their use in tissue engineered devices. The principles of polymeric device development for therapeutic growth factor delivery in the context of tissue engineering are outlined. A review of experimental evidence illustrates examples of growth factor delivery from devices such as micropaticles. scaffolds, and encapsulated cells, for their use in the application areas of musculoskeletal tissue, neural tissue, and hepatic tissue.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据